Addex Therapeutics Ltd. (ADXN)
3.18
+0.08
(+2.58%)
USD |
NASDAQ |
Oct 06, 16:00
2.97
-0.21
(-6.60%)
After-Hours: 18:36
Addex Therapeutics Price to Book Value : 1.430 for Oct. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 05, 2026 | 1.394 |
| October 02, 2026 | 1.381 |
| October 01, 2026 | 1.340 |
| September 30, 2026 | 1.241 |
| September 29, 2026 | 1.327 |
| September 28, 2026 | 1.264 |
| September 25, 2026 | 1.641 |
| September 24, 2026 | 1.556 |
| September 23, 2026 | 1.552 |
| September 22, 2026 | 1.574 |
| September 21, 2026 | 1.588 |
| September 18, 2026 | 1.529 |
| September 17, 2026 | 1.511 |
| September 16, 2026 | 1.511 |
| September 15, 2026 | 1.466 |
| September 14, 2026 | 1.565 |
| September 11, 2026 | 1.570 |
| September 10, 2026 | 1.524 |
| September 09, 2026 | 1.623 |
| September 08, 2026 | 1.664 |
| September 04, 2026 | 1.641 |
| September 03, 2026 | 1.668 |
| September 02, 2026 | 1.583 |
| September 01, 2026 | 1.641 |
| August 31, 2026 | 1.763 |
| Date | Value |
|---|---|
| August 28, 2026 | 1.727 |
| August 27, 2026 | 1.731 |
| August 26, 2026 | 1.902 |
| August 25, 2026 | 1.754 |
| August 24, 2026 | 1.821 |
| August 21, 2026 | 2.222 |
| August 20, 2026 | 2.055 |
| August 19, 2026 | 2.563 |
| August 18, 2026 | 2.563 |
| August 17, 2026 | 2.563 |
| August 14, 2026 | 2.676 |
| August 13, 2026 | 2.676 |
| August 12, 2026 | 2.676 |
| August 11, 2026 | 2.676 |
| August 10, 2026 | 2.676 |
| August 07, 2026 | 2.608 |
| August 06, 2026 | 2.608 |
| August 05, 2026 | 2.559 |
| August 04, 2026 | 2.559 |
| August 03, 2026 | 2.338 |
| July 31, 2026 | 2.338 |
| July 30, 2026 | 2.516 |
| July 29, 2026 | 2.646 |
| July 28, 2026 | 2.646 |
| July 27, 2026 | 2.646 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Novartis AG | 6.202 |
| Roche Holding AG | -- |
| Oculis Holding AG | 1.980 |
| Sandoz Group AG | -- |
| Galderma Group AG | -- |
Price to Book Value Related Metrics
| PS Ratio | 29.99 |
| PEG Ratio | -0.0957 |
| Price | 3.18 |
| Earnings Yield | -277.1% |
| Market Cap | 3.377M |
| PEGY Ratio | -0.0957 |